Company Profile

Partek Inc
Profile last edited on: 5/23/19      CAGE: 1TCA9      UEI: GCFJKHNPZM21

Business Identifier: Software for integrated genomics and microarray/sequencing technologies
Year Founded
1993
First Award
2009
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

624 Trade Center Boulevard
St. Louis, MO 63005
   (314) 878-2329
   inquire@partek.com
   www.partek.com
Location: Single
Congr. District: 02
County: St. Louis

Public Profile

With the defined objective of offering quality genomic analysis software to enable researchers to increase their understanding of genetics, diseases, and disease treatments. Specializing in innovative solutions for integrated genomics, big data, and mobile cloud computing, through close collaborations with technology providers and researchers worldwide, Partek® Genomics Suite™ - the firm’s flagship software - provides innovative solutions for integrated genomics supporting all microarray and next generation sequencing technologies including gene expression and digital gene expression, alternative splicing and RNA-seq, copy number and association, ChIP-chip, ChIP-seq, and microRNA. The firm’s methods are numerically driven, and presented with unique, powerful, and interactive visualizations.The firm's software has been cited in thousands of peer-reviewed scientific publications and appeared in numerous high impact jour

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
75-99
Revenue Range
7.5M-10M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $2,121,611
Project Title: Computational Tools to Analyze SNP Data from Patients with Mental Illness

Key People / Management

  Thomas Downey -- President and CEO